ADMA

美 　英

• 網(wǎng)絡(luò)不對稱二甲基精氨酸；非對稱性二甲基精氨酸；營銷協(xié)會

例句

The ADMA plasma level also tended to increase with an increasing number of classic cardiovascular risk factors, the researchers note.

研究者還注意到：ADMA血漿水平傾向于隨著傳統(tǒng)的心血管風(fēng)險因子種類的增加而增加。

Asymmetric Dimethylarginine (ADMA) is an endogenous inhibitor of NOS which can competitively inhibit NO production.

非對稱二甲基精氨酸（ADMA）是一種內(nèi)源性NOS抑制劑，能競爭性的抑制NO的生成。

Furthermore, increased ADMA levels tended to contribute to increased risk of progressive diabetic kidney disease.

并且ADMA水平升高促進糖尿病腎病發(fā)展。

There is abundant evidence that ADMA may be a novel risk factor for cardiovascular disease.

大量研究證明，ADMA可能是心血管疾病的一個新的危險因子。

Conclusions: Plasma ADMA levels predict fatal and non-fatal cardiovascular events in patients with type 1 nephropathy.

結(jié)論：在1型糖尿病腎病病人，血漿中ADMA水平可預(yù)測致命與非致命性心血管事件。

In a healthy human body, the majority of ADMA is eliminated through active metabolism by DDAH.

在健康人體內(nèi)，大部分ADMA通過DDAH的活性代謝而被清除。

ADMA was detected by HPLC-fluorescence method, and ET-1 was detected by radio-immunity method.

ADMA采用高效液相色譜-熒光法檢測，ET-1采用放射免疫法檢測。

The Role Of ADMA in Cardiovascular Complication of Patients in Chronic Kidney Disease

ADMA在慢性腎臟疾病患者并發(fā)心血管疾病中的作用